BriaCell raises $3.05M in public offering of 762,500 common shares at $4.00/share

BriaCell Therapeutics Corp.

Closed best-efforts offering of 762,500 common shares at $4.00/share on Feb 5, 2025; gross proceeds $3.05M.
Net proceeds to be used for working capital, general corporate purposes, and advancement of business objectives.
ThinkEquity acted as sole placement agent; received 7.5% cash fee and warrants to purchase 38,125 shares at $5.00/share (5-year term).
Offering conducted under effective shelf registration S-3; TSX exemption relied upon for listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.